The historic rise of Viagra has consistently remained a symbol of pharmaceutical success, yet its legacy within the broader market now triggers questions about future gains. Alternative versions are undercutting exclusivity , causing worries that supporting companies significantly dependent to Viagra's previous standing could be a problematic decis